Organised in collaboration with researchers at Imperial College London, this highly relevant meeting explored the new world of the microbiome in medicine, with a focus on microbes in cancer aetiology and therapeutics.
Useful for trainees of all discipline, the microbiome represents a developing field that is likely to become increasingly relevant in day-to-day clinical practice.
The microbiome refers to the collective genome of our 100 trillion strong host of resident bacteria, yeasts and viruses which cultivate every niche of our bodies. This internal ecosystem has garnered increasing interest for its role in development, immune regulation and metabolism and is starting to be considered an organ system.
Microbiome in Cancer and Beyond 2017 explored the role of the microbiome in the pathogenesis of cancer, the current state of knowledge and how this research could shape the future of clinical practice.
